NCT05618067

Brief Summary

This study is being to see if participating in breathing exercise training and practicing this training will help with Postural tachycardia syndrome (POTS). The information may help doctors to learn more about how the different parts of people's brains communicate.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
32mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Apr 2026Dec 2028

First Submitted

Initial submission to the registry

November 9, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 16, 2022

Completed
3.4 years until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

2.7 years

First QC Date

November 9, 2022

Last Update Submit

February 17, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in periaqueductal gray region (PAG) activation - looming task

    Functional magnetic resonance imaging (fMRI) will be performed to measure activation of the PAG region during the looming task

    90 minutes

  • Change in PAG activation - resting

    Functional magnetic resonance imaging (fMRI) will be performed to measure activation of the PAG region while at rest

    90 minutes

  • Change in Heart Rate Variability (HRV)

    HRV will be measured using an ear clip and/or wristband and results will be recorded automatically in the app

    Assessed for 2 days each week for the duration of the study (6 weeks).

Secondary Outcomes (10)

  • Change in Fatigue Severity Scale (FSS) score from baseline

    Assessed at baseline, week 3, and week 6 (final visit).

  • Change in Generalized Anxiety Disorder Scale (GAD-2) score from baseline

    Assessed at baseline, week 3, and week 6 (final visit).

  • Differences in Adverse Childhood Experiences (ACE) scores between participants

    Assessed at baseline.

  • Change in Pain Catastrophizing Scale (PCS) score from baseline

    Assessed at baseline, week 3, and week 6 (final visit).

  • Change in Patient Health Questionnaire (PHQ-9) score from baseline

    Assessed at baseline, week 3, and week 6 (final visit).

  • +5 more secondary outcomes

Study Arms (1)

Training

EXPERIMENTAL
Behavioral: breathing exercise training

Interventions

Participants will engage in weekly breathing exercises. They will be trained once a week for 4 weeks, and will use an app called Inner Balance and an device called Firstbeat Bodyguard 3 to track data about their hearts while practicing the exercises at home for 10 minutes a day, twice a day, once before bedtime.

Training

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-50 years
  • Diagnosis of POTS, orthostatic intolerance (with or without syncope), syncope, or near-syncope
  • Can speak and read in English
  • Upcoming new patient VCU Comprehensive Autonomics Center clinic visit scheduled at least 1 week in the future

You may not qualify if:

  • Inflammatory arthritis, connective tissue or auto-immune disorder
  • Any chronic neurological disorder besides POTS, orthostatic intolerance (with or without syncope), syncope, or near-syncope
  • Patients who have already had a new patient clinic visit where they were exposed to breathing exercise education
  • Evidence of unstable medical disorder, such as kidney (rising creatinine, or end-stage renal failure) or liver impairment (rising AST or ALT, or end-stage with coagulopathy), poorly controlled significant cardiovascular (CHF), respiratory, endocrine (diabetes - A1c \> 9 - or untreated thyroid dysfunction) or uncontrolled psychiatric illness (such as untreated depression, psychosis, etc.)
  • Neuropathy, central nervous system disorder (e.g., Cerebral palsy, developmental delay, seizure disorder, MS, stroke, etc.)
  • Treatment with a drug or medical device within the previous 30 days that has not received regulatory approval
  • Use of hormones (except insulin, thyroid replacement or oral contraceptives, which will be carefully documented)
  • Current substance or alcohol abuse
  • Any major surgical intervention with general anesthesia in the last 60 days and minor procedure, such as tooth extraction, endoscopy, etc., with local or conscious sedation within 7 days
  • Any on-going or pending medical, health or disability related litigation, or current pursuit of disability
  • Any condition that in the judgment of the investigator would interfere with the patient's ability to provide informed consent, comply with study instructions, place the patient at increased risk, or which would clearly confound the interpretation of the study results (specific reason will be documented)
  • Chronic use of narcotics for pain
  • Claustrophobia or any metal hardware that may interfere with MRI
  • Investigators and study staff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virnigia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Conditions

Postural Orthostatic Tachycardia Syndrome

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

Orthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Thomas Chelimsky, M.D.

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Madison Maxwell, B.S.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2022

First Posted

November 16, 2022

Study Start

April 1, 2026

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations